S_ry Cytogenetic analysis was performed on short-term cell cultures of two foci (A and B) (Holland et al., 1985; Dawson, 1993 (Sobin, 1981) . Cells from the material intended for cytogenetic study were short-term cultured and analysed as described by Pandis et al. (1992a) . The clonality criteria and the description of karyotypes followed the recommendations of the ISCN (1991 
Breast cancer is not only a common and often deadly disease, but one that is noted for its clinical unpredictability (Harris et al., 1992) . One of the striking facets of breast carcinomas is the pronounced phenotypic heterogeneity that exists among the cells of any given tumour; this feature has not been satisfactorily explained (Wolman & Heppner, 1992) . Another intriguing aspect is the multifocal distibution of the tumour tissue, with various degrees of histological differences among the foci, in perhaps as many as half of all breast cancer cases (Holland et al., 1985; Dawson, 1993) . This multifocality is of profound interest from at least two perspectives. First, with the advent in recent years of breastconserving surgery as a major therapeutic modality it has become increasingly important to know how frequently tumorous lesions are left behind, and how likely these are to give rise to local recrencs. Second, the pathogenetic implications of the observed multifocality must receive due attention. Is it the result of intramanmary spread from a single primary tumour or are we witnesig synchronous malignant transformation in a field of epithelial cells?
Some data indiate that acquired genetic differences play a major role in generating phenotypic heterogeneity in breast carcinomas, be they multifocal or not. Measurements of DNA content have demonstrated that genomic differences exist within tumours: multiple DNA stlines were detected in 40% of intraductal breast carcinomas by image cytophotometric DNA analysis (Crissman et al., 1990) and flow cytometric variation in the DNA histograms among distinct tumour samples was reported by Kallioniemi (1988) (Sobin, 1981) . Cells from the material intended for cytogenetic study were short-term cultured and analysed as described by Pandis et al. (1992a) . The clonality criteria and the description of karyotypes followed the recommendations of the ISCN (1991 (Figures 1-3) . In case I, 50 metaphases from each sample were karyotyped. Four clones were found in sample A: three (la, lb and Ic; Table I ) highly complex, related clones and one unrelated clone (2) with only a simple structural abnormality. In sample B, two of the three related clones present in A were identified (la and lb), but also a third subclone (ld), showing a pattern of clonal evolution partly different from that detected in sample A, was found. In addition, the unrelated clone seen in A (2) was identified as a clone in the B sample too, as were also two other unrelated clones (3 and 4). Four and seven cells with non-clonal changes were found in samples A and B respectively. A normal female complement was found in four metaphases in A and in 14 metaphases in B. In addition to the completely analysed cells in each sample, all the remaining metaphases detected (250 in A and 300 in B) were screened for the presence of the clonal aberrations found in the opposite sample; thus the total number of metaphases examined in case I was 650.
In case 1I, 50 metaphases were karyotyped from each sample. Two and three unrelated clones were found in samples A and B respectively; only one of these clones (1) Pandis et al., 1993a, b) , but the rest were cytogenetically unrelated Geleick et al., 1990; Pandis et al., 1993a; Thompson et al., 1993) . This karyotypic heterogeneity may at least partially explain the remarkable phenotypic heterogeneity seen at the cellular level in breast carcinomas (Heppner, 1984) . The frequency with which unrelated clones are identified in breast carcinomas is obviously technique dependent; after the introduction of improved methods for the short-term culture and cytogenetic analysis of these tumours (Pandis et al., 1992a) , cytogenetically unrelated clones could be detected in onethird to one-half of all cases with an abnormal chromosome complement (Pandis et al., 1993a (Pandis et al., , 1994a (Nowell, 1986; Heim, 1993) . (Orndal et al., 1993a, b Tlhere is presently no way to falsify conclusively any of the hypotheses listed above, let alone corroborate any of them. On balnce, however, we tend to favour the multiclonal origin model as the one that best accommodates the data.
The findings in case I are particularly pertinent. There can be little doubt about the pathogenetic relevance of the four related clones la-d (the karyotype was complex, with no less than 14 chromosomes involved in structural rearrangements; Figure 2 ), but also some of the aberrations in the unreated clones (Figure 3 ) are known to occur non-randomly in breast cancer cells. The i(lXqlO) found in sample B in clonal proportions has been registered in almost 10% of previously reported cases (Mitelnan, 1994) and is known to occur also as the sole chromosomal abnormality in a subset of breast carcinomas karyotypically defined by net gain of Iq (Pandis et al., 1992b) . Likewise, chromosome band 3p13 (clone 4, case I) is known to be frequently rearranged in breast cancers and the two deletions del(lXql 1) and del(6)(q21) (clones 1 and 3, case It) are also common in this tumour type (Pandis et al., 1993b (Pandis et al., , 1994a , all of which constitutes circumstantial evidence that these anomalies existed in cells that were part of the neoplastic parenchyma. Doubts about the pathogenetic role of these clones based on the fact that they encompassed only a small number of cells seem to us to be unfounded (see below); at any rate, the clonal size argument cannot be used for clone 2 of case I, which was large and with only a simple structural rearrangement, but was present in both macroscopically distinct foci.
The data we present and the interpretation that they reflect a multicellular tumour origin would seem to run counter to the extensive body of evidence, obtained by both cytogenetic and other methods, that tumorigenesis is monoclonal (Wainscoat & Fey, 1990) . In a study of 20 breast carcinomas using polymerase chain reaction-based analysis of the X-linked PGK gene, Noguchi et al. (1992) found the same X chromosome to be inactivated in each tumour, indicating that all the carcinomas were monoclonal. However, this type of investiTumour I gation only detects a monoclonal component against a polyclonal background if the monoclonal cell population makes up 50% of the total or more. The method therefore has an inherent 'winner takes all' bias, and so the presence of additional, independent, smaller clones cannot be said to be ruled out by the findings. Cytogenetic support for the general conclusion that tumours are monoclonal largely stems from investigations of haematological and mesenchymal neoplasms. At the same time, karyotypic evidence of polyclonality is increasingly being found in carcinomas (Heim et al., 1989a; Jin et al., 1990a, b; Pandis et al., 1992b Pandis et al., , 1993a Pandis et al., , b, 1994a Bardi et al., 1993) (Mitelman, 1994) -is only a weak indication that the tumour was also initially monoclonal: absence of evidence is no evidence of absence. Initial multiclonality may well give way to pseudomonoclonality when the selection forces in the tissue change, for example when the neoplastic cells penetrate the basal lamina and start to infiltrate locally (Heim et al., 1988) . This kind of in vivo Darwinian selection acting on the tumour cell population during the various stages of neoplastic development and progression could conceivably be the explanation for the asymmetric distribution of the observed clones between the foci in the three cases we describe. In vitro stochastic as well as systematic factors such as those discussed in the foregoing passages may equally well explain the interfocal differences, however, which is why we do not dare to speculate further on the evolutionary relationship between the tumour foci.
We conclude that the existing, admittedly very limited. cytogenetic evidence indicates that multifocal breast carcinoma is the result of intramammary spread from a primary tumour focus. The clonal nature of breast carcinomas remains unresolved, and we second the conclusion of Devilee and Cornelisse (1990) 
